These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 18392213)

  • 1. The early effects of elevated glucose on endothelial function as a target in the treatment of type 2 diabetes.
    Triggle CR
    Timely Top Med Cardiovasc Dis; 2008 Feb; 12():E3. PubMed ID: 18392213
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The early effects of elevated glucose on endothelial function as a target in the treatment of type 2 diabetes.
    Triggle CR
    Drugs Today (Barc); 2007 Nov; 43(11):815-26. PubMed ID: 18174967
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The role of postprandial hyperglycemia in the development of cardiovascular diseases in type 2 diabetes mellitus].
    Shvarts V
    Klin Med (Mosk); 2009; 87(11):17-24. PubMed ID: 20143560
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular mechanism for accelerated atherosclerosis in diabetes and its potential therapeutic intervention.
    Yamagishi S; Nakamura K; Takeuchi M; Imaizumi T
    Int J Clin Pharmacol Res; 2004; 24(4):129-34. PubMed ID: 15754918
    [TBL] [Abstract][Full Text] [Related]  

  • 5. From hyperglycemia to the risk of cardiovascular disease.
    Leiter LA
    Rev Cardiovasc Med; 2006; 7 Suppl 2():S3-9. PubMed ID: 17224875
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Benfotiamine prevents macro- and microvascular endothelial dysfunction and oxidative stress following a meal rich in advanced glycation end products in individuals with type 2 diabetes.
    Stirban A; Negrean M; Stratmann B; Gawlowski T; Horstmann T; Götting C; Kleesiek K; Mueller-Roesel M; Koschinsky T; Uribarri J; Vlassara H; Tschoepe D
    Diabetes Care; 2006 Sep; 29(9):2064-71. PubMed ID: 16936154
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute glucose fluctuations and chronic sustained hyperglycemia as risk factors for cardiovascular diseases in patients with type 2 diabetes.
    Colette C; Monnier L
    Horm Metab Res; 2007 Sep; 39(9):683-6. PubMed ID: 17846977
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The endothelial dysfunction in diabetes mellitus.
    Pănuş C; Moţa M; Vladu D; Vanghelie L; Răducanu CL
    Rom J Intern Med; 2003; 41(1):27-33. PubMed ID: 15529582
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Natural history of cardiovascular disease in patients with diabetes: role of hyperglycemia.
    Milicevic Z; Raz I; Beattie SD; Campaigne BN; Sarwat S; Gromniak E; Kowalska I; Galic E; Tan M; Hanefeld M
    Diabetes Care; 2008 Feb; 31 Suppl 2():S155-60. PubMed ID: 18227478
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Defining the role of incretin mimetic therapy in the management of type 2 diabetes.
    Unger J; Nadeau DA
    J Fam Pract; 2007 Dec; 56(12 Suppl New):S4-S10. PubMed ID: 18664341
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Hyperglycemia and vascular damage role of oxidative stress].
    Esposito K; Giugliano D
    Recenti Prog Med; 2002 Mar; 93(3):172-4. PubMed ID: 11942168
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiovascular risk factors in type 2 diabetes: the role of hyperglycaemia.
    Massi-Benedetti M; Federici MO
    Exp Clin Endocrinol Diabetes; 1999; 107 Suppl 4():S120-3. PubMed ID: 10522835
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diabetes and cardiovascular disease: explaining the relationship.
    Punthakee Z; Werstuck GH; Gerstein HC
    Rev Cardiovasc Med; 2007; 8(3):145-53. PubMed ID: 17938614
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of hyperglycemia and insulin with diabetic cardiovascular complications.
    Khamaisi M; Wainstein J; Hancu N; Milicevic Z; Raz I
    Isr Med Assoc J; 2003 Feb; 5(2):116-9. PubMed ID: 12674662
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of postprandial hyperglycemia in cardiovascular disease.
    Fava S
    Expert Rev Cardiovasc Ther; 2008 Jul; 6(6):859-72. PubMed ID: 18570623
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hyperglycaemia and its relation to cardiovascular morbidity and mortality: has it been resolved?
    Yosefy C
    Acta Diabetol; 2003 Dec; 40 Suppl 2():S380-8. PubMed ID: 14704873
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Hyperglycemia and cardiovascular events].
    Schneider CA; Gallwitz B; Hanefeld M; Leschke M; Müller-Wieland D; Zeymer U; Erdmann E
    Dtsch Med Wochenschr; 2004 Nov; 129(47):2553-7. PubMed ID: 15543474
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Importance of the post-prandial glycemia in the management of type 2 diabetes].
    Raguso CA; Helary C; Philippe J
    Rev Med Suisse; 2008 Jun; 4(160):1383-6. PubMed ID: 18630060
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Receptor for advanced glycation end products and the cardiovascular complications of diabetes and beyond: lessons from AGEing.
    Yan SF; Yan SD; Herold K; Ramsamy R; Schmidt AM
    Endocrinol Metab Clin North Am; 2006 Sep; 35(3):511-24, viii. PubMed ID: 16959583
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hyperglycemia and hyperlipidemia are associated with endothelial dysfunction during the development of type 2 diabetes.
    Okon EB; Chung AW; Zhang H; Laher I; van Breemen C
    Can J Physiol Pharmacol; 2007 May; 85(5):562-7. PubMed ID: 17632592
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.